Prazitone
From WikiProjectMed
Jump to navigation
Jump to search
Chemical compound
Clinical data | |
---|---|
Other names | 5-phenyl-5-(2-piperidylmethyl)barbituric acid |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C16H19N3O3 |
Molar mass | 301.346 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Prazitone (AGN-511) is a barbiturate derivative developed in the 1970s.[1] Unlike most barbiturates, it has little or no sedative effects, instead acting as a non-sedating anxiolytic and antidepressant.[2] The dosage range in humans is around 200–600 mg, although higher doses have been used in trials for the treatment of depression associated with Parkinson's disease.
References
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
|
This article about an anxiolytic is a stub. You can help Wikipedia by expanding it. |
Retrieved from "https://mdwiki.org/wiki/Prazitone"
Categories:
- Articles with short description
- Short description matches Wikidata
- Drugs not assigned an ATC code
- Articles with changed ChemSpider identifier
- Articles with changed InChI identifier
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Antidepressants
- Anxiolytics
- Barbiturates
- Piperidines
- Pyrimidines
- All stub articles
- Psychoactive drug stubs